Date
- 2024 (11)
- 2023 (46)
- 2022 (38)
- 2021 (36)
- 2020 (58)
- 2019 (31)
- 2018 (47)
- 2017 (12)
- 2016 (44)
- 2015 (37)
- 2014 (10)
- 2013 (12)
- 2012 (6)
- 2011 (6)
- 2010 (28)
- 2009 (4)
- 2008 (15)
- 2007 (1)
- 2006 (4)
- 2005 (11)
- 2004 (4)
- 2003 (5)
- 2002 (7)
- 2001 (5)
- 2000 (8)
- 1999 (2)
- 1998 (2)
- 1997 (4)
- 1996 (4)
- 1995 (4)
- 1993 (10)
- 1992 (3)
- 1991 (18)
Results for
"[search-keyword]"
Sponsor content
533 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOLAIR omalizumab (rch) 300 mg solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOLAIR omalizumab (rch) 150 mg solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOLAIR omalizumab (rch) 300 mg solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FABHALTA iptacopan 200 mg hard capsules blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PLUVICTO lutetium (177Lu) vipivotide tetraxetan 1000 MBq/mL solution for injection vial.
-
Prescription medicine registrationActive ingredients: iptacopan.
-
Prescription medicine registrationActive ingredients: lutetium (177Lu) vipivotide tetraxetan.
-
Jul-2024Prescription medicine evaluationActive ingredient: Canakinumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AVLOIRE carbamazepine 100 mg tablet blister pack.